Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07286383 · ClinicalTrials.gov registry record · Phase 3
Testing the Use of VA Peer Specialists to Prevent Veteran Suicide
A Phase 3 study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- Phase 3
- Development phase
- 306
- Enrollment target
NCT07286383: Clinical Trial Phase 3 study, sponsored by VA Office of Research and Development.
NCT07286383 is a Phase 3 study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 306 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07286383, a Phase 3 study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 306 participants
- Enrollment target
Study Summary
This study examines a novel way to prevent suicide among Veterans with serious mental illness (SMI). It will assess the efficacy of PREVAIL-VA, a 3-month intervention of 12, one-on-one sessions between a Peer Specialist (PS) and a Veteran that involve semi-structured conversations focused on hope, belongingness, support, and safety. PSs are Veterans with SMI trained to use their own experience and recovery to help other Veterans with SMI. PSs have improved mental health outcomes in other research, but this study would be the first to test their efficacy for suicide prevention in VHA. The project will compare outcomes of Veterans at risk for suicide receiving usual care, to PREVAIL-VA. This work is responsive to national calls for Veterans with SMI to receive support that is evidence-based, improves recovery (not just symptoms), and is tailored to individual needs. If successful, PREVAIL-VA could be adopted by the 1400 Peer Specialists employed in VA, greatly increasing the delivery of evidence-based services to Veterans at risk for suicide.
Interventions
- BEHAVIORAL PREVAIL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2029-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07286383
The ClinicalTrials.gov registry entry for NCT07286383 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 306 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PREVAIL is the first listed.
NCT07286383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07286383 about?
NCT07286383 is a clinical study titled "Testing the Use of VA Peer Specialists to Prevent Veteran Suicide". This study examines a novel way to prevent suicide among Veterans with serious mental illness (SMI). It will assess the efficacy of PREVAIL-VA, a 3-month intervention of 12, one-on-one sessions between a Peer Specialist (PS) and a Veteran that involve semi-structured conversations focused on hope, b...
What is the current status of trial NCT07286383?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 306 participants. The study started on 2026-07-01. Estimated completion is 2029-12-31.
What interventions are being tested in trial NCT07286383?
The interventions under investigation include: PREVAIL (BEHAVIORAL).
Who is sponsoring clinical trial NCT07286383?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.